Osphos, one of two bisphosphonates FDA-approved for use in horses four years old and up
An advisory from the office of the New York State Gaming Commission’s Equine Medical Director was disseminated on Monday:
As of Oct. 26, 2021, the New York Drug Testing and Research Program will commence testing of biologic samples for the presence of bisphosphonates. Absent written Commission approval of a valid Therapeutic Use Exemption, detection of bisphosphonate compounds in biologic samples obtained from 2-year-old and 3-year-old Thoroughbred racehorses will be considered by the Commission to be evidence of a violation of 9 NYCRR 4043.12(c) for which a fine of $25,000 and loss of occupational license may be imposed.
Horses testing positive for bisphosphonates will not be permitted to race until such time as they are re-tested and found to be clear of bisphosphonate compounds.
Background
On March 28, 2019, the Office of the Equine Medical Director issued two advisories regarding the use of bisphosphonates. The first advisory recommended that no bisphosphonate be administered to a racehorse that is less than four years old.
The second advisory warned that Thoroughbred horse owners, trainers, and/or veterinarians had a responsibility to guard against an impermissible administration of a bisphosphonate to a racehorse under potential penalty.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2021 Paulick Report.
